These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Mutations along transmembrane segment II of the NK-1 receptor affect substance P competition with non-peptide antagonists but not substance P binding. Rosenkilde MM; Cahir M; Gether U; Hjorth SA; Schwartz TW J Biol Chem; 1994 Nov; 269(45):28160-4. PubMed ID: 7525569 [TBL] [Abstract][Full Text] [Related]
4. Point mutation increases a form of the NK1 receptor with high affinity for neurokinin A and B and septide. Ciucci A; Palma C; Manzini S; Werge TM Br J Pharmacol; 1998 Sep; 125(2):393-401. PubMed ID: 9786514 [TBL] [Abstract][Full Text] [Related]
5. Autoradiographic localization of tachykinin NK2 and NK1 receptors in the guinea-pig lung, using selective radioligands. Strigas J; Burcher E Eur J Pharmacol; 1996 Sep; 311(2-3):177-86. PubMed ID: 8891598 [TBL] [Abstract][Full Text] [Related]
6. The unpredicted high affinities of a large number of naturally occurring tachykinins for chimeric NK1/NK3 receptors suggest a role for an inhibitory domain in determining receptor specificity. Tian Y; Wu LH; Oxender DL; Chung FZ J Biol Chem; 1996 Aug; 271(34):20250-7. PubMed ID: 8702757 [TBL] [Abstract][Full Text] [Related]
7. Mapping the ligand binding site of the NK-1 receptor. Fong TM; Huang RR; Yu H; Strader CD Regul Pept; 1993 Jul; 46(1-2):43-8. PubMed ID: 8210503 [No Abstract] [Full Text] [Related]
8. Identification in the NK1 tachykinin receptor of a domain involved in recognition of neurokinin A and septide but not of substance P. Wijkhuisen A; Sagot MA; Frobert Y; Créminon C; Grassi J; Boquet D; Couraud JY FEBS Lett; 1999 Mar; 447(2-3):155-9. PubMed ID: 10214937 [TBL] [Abstract][Full Text] [Related]
9. Two nonpeptide tachykinin antagonists act through epitopes on corresponding segments of the NK1 and NK2 receptors. Gether U; Yokota Y; Emonds-Alt X; Brelière JC; Lowe JA; Snider RM; Nakanishi S; Schwartz TW Proc Natl Acad Sci U S A; 1993 Jul; 90(13):6194-8. PubMed ID: 7687062 [TBL] [Abstract][Full Text] [Related]
13. Contractile effect of tachykinins on Suncus murinus (house musk shrew) isolated ileum. Cheng FH; Chan SW; Rudd JA Neuropeptides; 2008; 42(5-6):671-9. PubMed ID: 18582934 [TBL] [Abstract][Full Text] [Related]
14. Septide and neurokinin A are high-affinity ligands on the NK-1 receptor: evidence from homologous versus heterologous binding analysis. Hastrup H; Schwartz TW FEBS Lett; 1996 Dec; 399(3):264-6. PubMed ID: 8985159 [TBL] [Abstract][Full Text] [Related]
15. The common C-terminal sequences of substance P and neurokinin A contact the same region of the NK-1 receptor. Bremer AA; Leeman SE; Boyd ND FEBS Lett; 2000 Dec; 486(1):43-8. PubMed ID: 11108840 [TBL] [Abstract][Full Text] [Related]
16. A flexible approach to the design of new potent substance P receptor ligands. Millet R; Goossens L; Bertrand-Caumont K; Goossens JF; Houssin R; Hénichart JP J Pharm Pharmacol; 2001 Jul; 53(7):929-34. PubMed ID: 11480541 [TBL] [Abstract][Full Text] [Related]
18. Comparison of tachykinin NK1 and NK2 receptors in the circular muscle of the guinea-pig ileum and proximal colon. Maggi CA; Patacchini R; Meini S; Quartara L; Sisto A; Potier E; Giuliani S; Giachetti A Br J Pharmacol; 1994 May; 112(1):150-60. PubMed ID: 7518302 [TBL] [Abstract][Full Text] [Related]
19. Neurokinin release in the rat nucleus of the solitary tract via NMDA and AMPA receptors. Colin I; Blondeau C; Baude A Neuroscience; 2002; 115(4):1023-33. PubMed ID: 12453476 [TBL] [Abstract][Full Text] [Related]
20. Substance P: structure, function, and therapeutics. Datar P; Srivastava S; Coutinho E; Govil G Curr Top Med Chem; 2004; 4(1):75-103. PubMed ID: 14754378 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]